Sally Smikahl
Senior Director, Regulatory Affairs at Corcept Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Stephen Woltosz
Sally is a powerhouse of knowledge, especially when it comes to pharm dev regulatory affairs. She is very professional and detailed oriented, makes meetings worth going to, and engages in lively and enjoyable conversations. Technically speaking, she is at the top of the pack. Sally is also one of the most dedicated hard workers I’ve come across. We worked together on a very complex drug/device submission over several years. She was a go-to for help with strategic assessment, tactical development, crafting complex regulatory authoring for our regulatory development efforts. I look forward to working with Sally in the future.
Stephen Woltosz
Sally is a powerhouse of knowledge, especially when it comes to pharm dev regulatory affairs. She is very professional and detailed oriented, makes meetings worth going to, and engages in lively and enjoyable conversations. Technically speaking, she is at the top of the pack. Sally is also one of the most dedicated hard workers I’ve come across. We worked together on a very complex drug/device submission over several years. She was a go-to for help with strategic assessment, tactical development, crafting complex regulatory authoring for our regulatory development efforts. I look forward to working with Sally in the future.
Stephen Woltosz
Sally is a powerhouse of knowledge, especially when it comes to pharm dev regulatory affairs. She is very professional and detailed oriented, makes meetings worth going to, and engages in lively and enjoyable conversations. Technically speaking, she is at the top of the pack. Sally is also one of the most dedicated hard workers I’ve come across. We worked together on a very complex drug/device submission over several years. She was a go-to for help with strategic assessment, tactical development, crafting complex regulatory authoring for our regulatory development efforts. I look forward to working with Sally in the future.
Stephen Woltosz
Sally is a powerhouse of knowledge, especially when it comes to pharm dev regulatory affairs. She is very professional and detailed oriented, makes meetings worth going to, and engages in lively and enjoyable conversations. Technically speaking, she is at the top of the pack. Sally is also one of the most dedicated hard workers I’ve come across. We worked together on a very complex drug/device submission over several years. She was a go-to for help with strategic assessment, tactical development, crafting complex regulatory authoring for our regulatory development efforts. I look forward to working with Sally in the future.
Experience
-
Corcept Therapeutics
-
United States
-
Biotechnology Research
-
200 - 300 Employee
-
Senior Director, Regulatory Affairs
-
Apr 2016 - Present
-
-
-
Threshold Pharmaceuticals
-
South San Francisco, CA
-
Senior Director Regulatory Affairs
-
Sep 2012 - Apr 2016
-
-
-
XenoPort, Inc.
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Senior Director, Regulatory Affairs
-
Oct 2006 - Sep 2012
-
-
-
InBios International
-
Medical Equipment Manufacturing
-
100 - 200 Employee
-
Assoc. Dir, Regulatory Affairs
-
Apr 2005 - Oct 2006
-
-
-
Nektar Therapeutics
-
Biotechnology
-
300 - 400 Employee
-
Assoc Director, Regulatory Affairs
-
Jan 2001 - Apr 2005
-
-
-
Gilead Sciences
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Manager, Regulatory Affairs
-
Sep 1996 - Dec 2000
-
-
-
Genentech
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Associate, Regulatory Affairs
-
Jun 1991 - Sep 1996
-
-
-
Monsanto Company
-
United States
-
Farming
-
700 & Above Employee
-
Res. Pharm Scientist, II
-
Apr 1986 - May 1991
-
-
Education
-
1977 - 1980
Maryville University of Saint Louis
BS, Chemistry
Community
